Literature DB >> 7806291

Peptide motifs of HLA-B38 and B39 molecules.

K Falk1, O Rötzschke, M Takiguchi, V Gnau, S Stevanović, G Jung, H G Rammensee.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7806291     DOI: 10.1007/bf00182332

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  7 in total

1.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

2.  Identification of self peptides bound to purified HLA-B27.

Authors:  T S Jardetzky; W S Lane; R A Robinson; D R Madden; D C Wiley
Journal:  Nature       Date:  1991-09-26       Impact factor: 49.962

Review 3.  Consensus motifs and peptide ligands of MHC class I molecules.

Authors:  K Falk; O Rötzschke
Journal:  Semin Immunol       Date:  1993-04       Impact factor: 11.130

4.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs.

Authors:  O Rötzschke; K Falk; S Stevanović; V Gnau; G Jung; H G Rammensee
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

5.  Molecular analysis of HLA-B39 subtypes.

Authors:  N Kato; S Karaki; K Kashiwase; C Müller; T Akaza; T Juji; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

6.  Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.

Authors:  H C Guo; D R Madden; M L Silver; T S Jardetzky; J C Gorga; J L Strominger; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

7.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

  7 in total
  7 in total

1.  The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype.

Authors:  Kasper Lamberth; Gustav Røder; Mikkel Harndahl; Morten Nielsen; Claus Lundegaard; Claus Schafer-Nielsen; Ole Lund; Soren Buus
Journal:  Immunogenetics       Date:  2008-09-04       Impact factor: 2.846

2.  A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens.

Authors:  Adán Alpízar; Fabio Marino; Antonio Ramos-Fernández; Manuel Lombardía; Anita Jeko; Florencio Pazos; Alberto Paradela; César Santiago; Albert J R Heck; Miguel Marcilla
Journal:  Mol Cell Proteomics       Date:  2016-12-05       Impact factor: 5.911

Review 3.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands.

Authors:  Christina Bade-Doeding; Holger-Andreas Elsner; Britta Eiz-Vesper; Axel Seltsam; Ute Holtkamp; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2004-04-30       Impact factor: 2.846

5.  Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Elena Merino; José A López de Castro; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

6.  Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.

Authors:  John Sidney; Jennifer Schloss; Carrie Moore; Mikaela Lindvall; Amanda Wriston; Donald F Hunt; Jeffrey Shabanowitz; Teresa P DiLorenzo; Alessandro Sette
Journal:  Immunogenetics       Date:  2016-01-11       Impact factor: 3.330

7.  HLA-A2 subtypes are functionally distinct in peptide binding and presentation.

Authors:  D Barouch; T Friede; S Stevanović; L Tussey; K Smith; S Rowland-Jones; V Braud; A McMichael; H G Rammensee
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.